4D Molecular Therapeutics, Inc. FDMT
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
4D Molecular Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing genetic medicines for ophthalmology and pulmonology diseases. It utilizes its proprietary Therapeutic Vector Evolution platform to create customized adeno-associated virus vectors that enable targeted, durable delivery of th…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees196
TickerFDMT
Statistics
Market Cap$501.3M
Revenue (TTM)$85.2M
Net Income-$140.1M
Net Margin-164.4%
EPS$-2.42
P/E-3.65
P/S5.23
P/B1.02
EV/EBITDA-0.53
ROE-34.9%
Dividend Yield—
Price$9.59
Data: Twelve Data · Revenue = mcap / P/S